ArticleCureus2025
Access to Naloxone and Preferences for Its Online Purchase Among Individuals Affected by Opioid Misuse.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Naloxone is a lifesaving medication that can prevent deaths in opioid overdose situations. However, barriers to access and purchasing naloxone still exist. Online pharmacies present an important venue to expand access to naloxone. We examined the access to naloxone, counseling for opioid overdose prevention drugs, and preferences regarding online purchase of naloxone among individuals affected by opioid misuse. Methods We conducted an online survey among 504 individuals who were either personally affected or had family members/friends who were affected by the misuse of opioids. Results The study included participants from all 50 US states, among whom 37.5% were personally affected and 30.1% had a family/friend who was affected by opioid misuse. Although 40.3% were current or past users of heroin, and 91.1% of participants or their loved ones had taken prescription opioids, a majority (72.5%) had never purchased or been given a drug to prevent an opioid overdose. The most common barriers to purchasing naloxone included cost (60.5%), inability to get a prescription (30.9%), and unavailability at pharmacies (30.9%). About half of the participants (46.4%) indicated online pharmacy as their first choice for purchasing naloxone. Factors significantly associated with preferring online purchase of naloxone included not being comfortable with talking to a doctor/pharmacist regarding opioid use and previous experience of issues with purchasing naloxone. Conclusions Many individuals who might need naloxone face barriers to getting naloxone from a pharmacy. Availability of naloxone from online pharmacies and higher insurance coverage can significantly increase access and potentially reduce opioid overdose deaths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.